Pneumonia News and Research

Latest Pneumonia News and Research

Contaminant particles emitted by vehicles have negative repercussions in children with respiratory illnesses

Contaminant particles emitted by vehicles have negative repercussions in children with respiratory illnesses

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Amgen starts Phase 3 study assessing the benefit of Kyprolis in patients with relapsed/refractory multiple myeloma

Amgen starts Phase 3 study assessing the benefit of Kyprolis in patients with relapsed/refractory multiple myeloma

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes  in CLL/SLL patients

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

OncoGenex's Phase 3 SYNERGY trial shows survival benefits of custirsen therapy in CRPC patients with poor prognosis

OncoGenex's Phase 3 SYNERGY trial shows survival benefits of custirsen therapy in CRPC patients with poor prognosis

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

UT Southwestern Medical Center Performs its 500th Lung Transplant on Cystic Fibrosis Patient

UT Southwestern Medical Center Performs its 500th Lung Transplant on Cystic Fibrosis Patient

UB researchers successfully harness E. coli to generate new forms of antibiotics

UB researchers successfully harness E. coli to generate new forms of antibiotics

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Actavis creates collaborative program to improve care for patients with multidrug-resistant infections

Actavis creates collaborative program to improve care for patients with multidrug-resistant infections

Existing anti-stroke drug can be effective in treating middle-ear infections

Existing anti-stroke drug can be effective in treating middle-ear infections

ICS use may lower risk of mortality from pneumonia and other causes in COPD patients

ICS use may lower risk of mortality from pneumonia and other causes in COPD patients

Second-generation antibiotic shows promise against common bacterial infections

Second-generation antibiotic shows promise against common bacterial infections

Kidney function plays critical role in sepsis patients

Kidney function plays critical role in sepsis patients

Toxin pneumolysin causes progressive and fatal heart complications

Toxin pneumolysin causes progressive and fatal heart complications

No data exists to support long-term efficacy, safety of e-cigarettes as smoking cessation tool

No data exists to support long-term efficacy, safety of e-cigarettes as smoking cessation tool

Bronchitis can cause pneumonia, says Loyola physician

Bronchitis can cause pneumonia, says Loyola physician

WHO Press Release: World Health Statistics reports on global health goals for 194 countries

WHO Press Release: World Health Statistics reports on global health goals for 194 countries

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.